Pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Brawn Biotech has informed that the meeting of the Board of Directors of the company is scheduled to be held on Monday, 11th February, 2019 at 03:00 PM at the Registered Office of the Company situated at 4B, Asaf Ali Road, II Floor, Delhi Stock Exchange Building, New Delhi- 110002, to consider, approve and take on record the Un-audited Financial Results of the Company for the quarter ended December 31st, 2018. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that the trading window for dealing in the Securities of the Company will remain closed for promoters, directors, senior managerial personnel and other connected persons of the Company from 4th February, 2019 till 48 hours after the submission/ announcement of financial results of the Company to the stock exchange.
The above information is a part of company’s filings submitted to BSE.
